{"product_id":"bioresorbable-scaffolds-9781498779746","title":"Bioresorbable Scaffolds","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis book focuses on the coronary bioresorbable scaffold, a new interventional treatment for coronary artery disease, differentiated from a permanent metallic stent. The book provides an overview of the technology including non-clinical studies and clinical evidences in order to help clinicians understand the appropriate application of the technology and the optimal techniques of implantation. It covers the basics of bioresorbable scaffolds; bench test results; preclinical studies; clinical evidences; and tips and tricks of implantation.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eTable of Contents\u003c\/p\u003e\u003cp\u003eSection 1: Introduction\u003c\/p\u003e\u003cp\u003e1.1- Early development of bioresorbable scaffold\u003c\/p\u003e\u003cp\u003ePatrick W. Serruys\u003c\/p\u003e\u003cp\u003eSection 2: Principles of bioresorption, vascular application\u003c\/p\u003e\u003cp\u003e2.1- Degradable, biodegradable and bioresorbable polymers for time-limited therapy\u003c\/p\u003e\u003cp\u003eMichel Vert\u003c\/p\u003e\u003cp\u003e2.2- Lactic acid-based polymers in depth\u003c\/p\u003e\u003cp\u003eMichel Vert and Antoine Lafont\u003c\/p\u003e\u003cp\u003e2.3- Scaffold processing\u003c\/p\u003e\u003cp\u003eJack Scanlon\u003c\/p\u003e\u003cp\u003e2.4- Basics of biodegradation of magnesium\u003c\/p\u003e\u003cp\u003eMichael Haude, Daniel Lootz, Hubertus Degen and Matthias Epple\u003c\/p\u003e\u003cp\u003e2.5- Basics of biodegradation of iron scaffold\u003c\/p\u003e\u003cp\u003eDeyuan Zhang and Runlin Gao\u003c\/p\u003e\u003cp\u003eSection 3: From bench test to preclinical assessment\u003c\/p\u003e\u003cp\u003e3.1- Unlocking scaffold mechanical properties\u003c\/p\u003e\u003cp\u003eJack Scanlon, Yoshinobu Onuma, Patrick W. Serruys and Joseph Deitzel\u003c\/p\u003e\u003cp\u003e3.2- Bench testing for polymeric bioresorbable scaffolds\u003c\/p\u003e\u003cp\u003eJohn A. Ormiston, Bruce Webber, Janarthanan Sathananthan, Pau Medran-Gracia, Susann Beier and Mark WI Webster\u003c\/p\u003e\u003cp\u003e3.3- Bench test for magnesium scaffold\u003c\/p\u003e\u003cp\u003eDaniel Lootz, Wolfram Schmidt, Peter Behrens, Klaus-Peter Schmitz, Michael Haude and Ron Waksman\u003c\/p\u003e\u003cp\u003e3.4- Simulation of flow and shear stress\u003c\/p\u003e\u003cp\u003eNicolas Foin, Ryo Torii, Renick Darren Lee, Alessio Mattesini, Carlo Di Mario, Philip Wong, Erhan Tenekecioglu, Tom Crake, Christos Bourantas and Patrick W. Serruys\u003c\/p\u003e\u003cp\u003e3.5- Preclinical assessment of bioresorbable scaffolds and regulatory implication\u003c\/p\u003e\u003cp\u003eTobias Koppara, Eric Wittchow, Renu Virmani and Michael Joner\u003c\/p\u003e\u003cp\u003eSection 4: Lesson learned from preclinical assessment\u003c\/p\u003e\u003cp\u003e4.1- PLA scaffold\u003c\/p\u003e\u003cp\u003eKazuyuki Yahagi, Sho Torii, Erica Pacheco, Frank D. Kolodgie, Aloke V. Finn and Renu Virmani\u003c\/p\u003e\u003cp\u003e4.2- Iron\u003c\/p\u003e\u003cp\u003eRunlin Gao, Deyuan Zhang, Hong Qiu, Chao Wu, Ying Xia and Gui Zhang\u003c\/p\u003e\u003cp\u003eSection 5: Imaging to evaluate the bioresorbable scaffold: A corelab perspective, methodology of measurement and assessment\u003c\/p\u003e\u003cp\u003e5.1- Quantative coronary angiography of bioresorbable vascular scaffold: a corelab perspective\u003c\/p\u003e\u003cp\u003eYohei Sotomi, Patrick W. Serruys and Yoshinobu Onuma\u003c\/p\u003e\u003cp\u003e5.2- Assessment of bioresorbable scaffolds by IVUS: echogenicity, virtual histology and palpography\u003c\/p\u003e\u003cp\u003eCarlos M. Campos, Patrick W. Serruys and Hector M. Garcia-Garcia\u003c\/p\u003e\u003cp\u003e5.3- Optical coherence tomography analysis vascular scaffold in comparison with metallic stents: a corelab perspective\u003c\/p\u003e\u003cp\u003eYohei Sotomi, Pannipa Suwannasom, Jouke Dijkstra, Carlos Collet, Shimpei Nakatani, Patrick W. Serruys, Yoshinobu Onuma\u003c\/p\u003e\u003cp\u003e5.4- Non-invasive coronary tomography analysis after bioresorbable scaffold implantation\u003c\/p\u003e\u003cp\u003eCarlos Collet, Koen Nieman, Patrick W. Serruys and Yoshinobu Onuma\u003c\/p\u003e\u003cp\u003e5.5- Angiography is sufficient\u003c\/p\u003e\u003cp\u003eJ Ribamar Costa, Jr. and Alexandre Abizaid\u003c\/p\u003e\u003cp\u003e5.6- Intravascular ultrasound is a must in bioresorbable scaffold implantation\u003c\/p\u003e\u003cp\u003eHiroyoshi Kawamoto, Neil Ruparelia and Antonio Colombo\u003c\/p\u003e\u003cp\u003e5.7- OCT is the way to go\u003c\/p\u003e\u003cp\u003eJiang Ming Fam, Nienke Simone van Ditzhuijzen, Jors van Sjide, Bu Chan Zhang, Antonios Karanasos, Robert-Jan van Geuns and Evelyn Regar\u003c\/p\u003e\u003cp\u003e5.8- Imaging to evaluate the bioresorbable scaffold. Clinician’s perspective: I need both (IVUS and OCT)\u003c\/p\u003e\u003cp\u003eJosep Gomez-Lara and Antoni Serra\u003c\/p\u003e\u003cp\u003e5.9- Multislice computed tomography as a modality of follow-up\u003c\/p\u003e\u003cp\u003eAntonio L. Bartorelli, Daniele Andreini, Simona Espejo and Manuel Pan\u003c\/p\u003e\u003cp\u003eSection 6: Clinical evidence of randomised and non-randomised trials: personal perspective\u003c\/p\u003e\u003cp\u003e6.1- What are appropriate clinical endpoints? From device failure assessment to angina evaluation\u003c\/p\u003e\u003cp\u003eMaik J. Grundeken, Yoshinobu Onuma and Patrick W. Serruys\u003c\/p\u003e\u003cp\u003e6.2- Angina reduction after BRS implantation: correlation with changes in coronary haemodynamics\u003c\/p\u003e\u003cp\u003eNick E.J. West, Adam J. Brown and Stephen P. Hoole\u003c\/p\u003e\u003cp\u003e6.3- Comparison of everolimus eluting bioresorbable scaffolds with everolimus eluting metallic stents for treatment of coronary artery stenosis: Three-year follow-up of the Absorb II randomized trial\u003c\/p\u003e\u003cp\u003eCarlos Collet et al.\u003c\/p\u003e\u003cp\u003e6.4- The ABSORB China trial\u003c\/p\u003e\u003cp\u003eRunlin Gao\u003c\/p\u003e\u003cp\u003e6.5- ABSORB Japan\u003c\/p\u003e\u003cp\u003eTakeshi Kimura\u003c\/p\u003e\u003cp\u003e6.6- What have we learned from meta-analysis of 1 year outcomes with the Absorb bioresorbable scaffold in patients with coronary heart disease\u003c\/p\u003e\u003cp\u003eYohei Sotomi, Carlos Collet, Takeshi Kimura, Runlin Gao, Dean J. Kereiakes, Gregg W. Stone, Stephen G. Ellis, Yoshinobu Onuma and Patrick W. Serruys\u003c\/p\u003e\u003cp\u003e6.7- Summary of investigator-driven registries on absorb bioresorbable vascular scaffolds\u003c\/p\u003e\u003cp\u003eAnna Franzone, Raffaele Piccolo and Stephen Windecker\u003c\/p\u003e\u003cp\u003e6.8- Investigator-driven randomised trials\u003c\/p\u003e\u003cp\u003eDaniele Giacoppo, Roisin Colleran and Adnan Kastrati\u003c\/p\u003e\u003cp\u003e6.9- The DESolve scaffold\u003c\/p\u003e\u003cp\u003eStefan Verheye, Nagarajan Ramesh, Lynn Morrison and Sara Toyloy\u003c\/p\u003e\u003cp\u003e6.10- Results of clinical trials with BIOTRONIK magnesium scaffolds\u003c\/p\u003e\u003cp\u003eMichael Haude, Daniel Lootz, Raimund Erbel, Jacques Koolen and Ron Waksman\u003c\/p\u003e\u003cp\u003e6.11- The REVA medical program: from ReZolve® to Fantom®\u003c\/p\u003e\u003cp\u003eAlexandre Abizaid and J. Ribamar Costa Jr.\u003c\/p\u003e\u003cp\u003e6.12- The Amaranth’s bioresorbable vascular scaffold technology\u003c\/p\u003e\u003cp\u003eAlaide Chieffo, Juan F. Granada and Antonio Colombo\u003c\/p\u003e\u003cp\u003e6.13- The mirage microfiber sirolimus eluting coronary scaffold\u003c\/p\u003e\u003cp\u003eTeguh Santoso, Liew Houng Bang, Ricardo Costa, Daniel Chamié, Solomon Su, Alexandre Abizaid, Yoshinobu Onuma and Patrick W. Serruys\u003c\/p\u003e\u003cp\u003e6.14- The Igaki-Tamai stent: the legacy of the work of Hideo Tamai\u003c\/p\u003e\u003cp\u003eSoji Nishio, Kunihiko Kosuga, Eisho Kyo, Takafumi Tsuji, Masaharu Okada, Shinsaku Takeda, Yasutaka Inuzuka, Tatsuhiko Hata, Yuzo Takeuchi, Junya Seki and Shigeru Ikeguchi\u003c\/p\u003e\u003cp\u003eSection 7: Clinical evidence in specific patient subsets: personal perspective\u003c\/p\u003e\u003cp\u003e7.1- Left main interventions with BRS\u003c\/p\u003e\u003cp\u003eBert Everaert, Piera Capranzano, Corrado Tamburino, Ashok Seth and Robert-Jan van Geuns\u003c\/p\u003e\u003cp\u003e7.2- Bioresorbable scaffolds in bifurcations\u003c\/p\u003e\u003cp\u003eFilippo Fingini, Hiroyoshi Kawamoto and Azeem Latib\u003c\/p\u003e\u003cp\u003e7.3- BVS in chronic total occlusions: clinical evidence, tips and tricks\u003c\/p\u003e\u003cp\u003eAntonio Serra\u003c\/p\u003e\u003cp\u003e7.4- Bioresorbable scaffolds in diffuse disease\u003c\/p\u003e\u003cp\u003eNeil Ruparelia, Hiroyoshi Kawamoto and Antonio Colombo\u003c\/p\u003e\u003cp\u003e7.5- Bioresorbable scaffolds in mulitvessel coronary disease\u003c\/p\u003e\u003cp\u003eR.P. Kraak, Maik J. Grundeken and J.J Wykrzykowska\u003c\/p\u003e\u003cp\u003e7.6- Bioresorbable coronary scaffolds in non-St elevation acute coronary syndromes\u003c\/p\u003e\u003cp\u003eCharis Mamilou and Tommaso Gori\u003c\/p\u003e\u003cp\u003e7.7- Bioresorbable vascular scaffold in ST-segment elevation myocardial infarction: clinical evidence, tips and tricks\u003c\/p\u003e\u003cp\u003eGiuseppe Giacchi and Manel Sabaté\u003c\/p\u003e\u003cp\u003e7.8- Bioresorbable scaffolds for treating coronary artery disease in patients with diabetes mellitus\u003c\/p\u003e\u003cp\u003eAyyaz Sultan, Takeshi Muramatsu and Javaid Iqbal\u003c\/p\u003e\u003cp\u003e7.9- BRS in calcified lesions\u003c\/p\u003e\u003cp\u003eAshok Seth\u003c\/p\u003e\u003cp\u003e7.10- BRS textbook: invasive sealing of vulnerable, high-risk lesions\u003c\/p\u003e\u003cp\u003eChristos Bourantas, Ryo Torri, Nicolas Foin, Ajay Suri, Erhan Tenekecioglu, Vikas Thondapu, Tom Crake, Peter Barlis and Patrick W. Serruys\u003c\/p\u003e\u003cp\u003eSection 8: Complications (incidence, diagnosis, potential mechanisms and treatment)\u003c\/p\u003e\u003cp\u003e8.1- Acute and subacute scaffold thrombosis\u003c\/p\u003e\u003cp\u003eDavide Capodanno\u003c\/p\u003e\u003cp\u003e8.2- Late and very late scaffold thrombosis\u003c\/p\u003e\u003cp\u003eAntonios Karanasos, Bu-Chun Zhang, Jors van der Sijde, Jiang-Ming Fam, Robert-Jan van Geuns and Evelyn Regar\u003c\/p\u003e\u003cp\u003e8.3- Treatment of bioresorbable scaffold failure\u003c\/p\u003e\u003cp\u003eCordula M. Felix, Bert Everaert, Nigel Jepson, Corrado Tamburino and Robert-Jan van Geuns\u003c\/p\u003e\u003cp\u003e8.4- Recoil and bioresorbable scaffolds\u003c\/p\u003e\u003cp\u003eJohn A. Ormiston, Bruce Webber, Janarthanan Sathananthan and Mark WI Webster\u003c\/p\u003e\u003cp\u003e8.5- Scaffold disruption and late discontinuities\u003c\/p\u003e\u003cp\u003eYoshinobu Onuma, Patrick W. Serruys\u003c\/p\u003e\u003cp\u003e8.6- The incidence, potential mechanism of side-branch occlusion after implantation of bioresorbable scaffold(s): insights from ABSORB II\u003c\/p\u003e\u003cp\u003eYuki Ishibashi, Takeshi Muramatsu, Yohei Sotomi, Yoshinobu Onuma and Patrick W. Serruys\u003c\/p\u003e\u003cp\u003eSection 9: Tips and tricks to implant BRS\u003c\/p\u003e\u003cp\u003e9.1- Tips and tricks for implanting BRS: sizing, pre- and post-dilatation\u003c\/p\u003e\u003cp\u003eAkihito Tanaka, Richard J. Jabbour and Antonio Colombo\u003c\/p\u003e\u003cp\u003e9.2- Approach to bifurcation lesions\u003c\/p\u003e\u003cp\u003eAshok Seth\u003c\/p\u003e\u003cp\u003eSection 10: Emerging technologies (pre-CE mark, pre-FA, pre-PMDA and pre-CFDA)\u003c\/p\u003e\u003cp\u003e10.1- Overview of the field\u003c\/p\u003e\u003cp\u003eYoshinobu Onuma\u003c\/p\u003e\u003cp\u003e10.2- MeRes100™- a sirolimus eluting bioresorbable vascular scaffold system\u003c\/p\u003e\u003cp\u003eAshok Seth, Babu Ezhumalai, Sanjeev Bhatt and Pratik Vasani\u003c\/p\u003e\u003cp\u003e10.3- XINSORB bioresorbable vascular scaffold\u003c\/p\u003e\u003cp\u003eJunbo Ge and Li Shen\u003c\/p\u003e\u003cp\u003e10.4- NeoVas™ bioresorbable coronary scaffold system\u003c\/p\u003e\u003cp\u003eHan Yangling\u003c\/p\u003e\u003cp\u003e10.5- ArterioSorb™ bioresorbable scaffold by Arterius Ltd\u003c\/p\u003e\u003cp\u003eRasha Al-Lamee\u003c\/p\u003e\u003cp\u003e10.6- Lifetech\u003c\/p\u003e\u003cp\u003eDeyuan Zhang, Wenjiao Lin, Haiping Oi\u003c\/p\u003e\u003cp\u003e10.7- Abbott: new generation absorb scaffold\u003c\/p\u003e\u003cp\u003eLaura E. Leigh Perkins, Byron J. Lambert and Richard J. Rapoza\u003c\/p\u003e","brand":"Taylor \u0026 Francis Inc","offers":[{"title":"Default Title","offer_id":49409297056087,"sku":"9781498779746","price":194.75,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781498779746.jpg?v=1730506326","url":"https:\/\/bookcurl.com\/products\/bioresorbable-scaffolds-9781498779746","provider":"Book Curl","version":"1.0","type":"link"}